Life
Sciences
We provide timely and accurate drug development and commercialization services from our U.S. owned and operated CDMO/CRO network.
improving our health
We believe the therapies our customers develop are critical to improving lives and we are proud to be a part.
-
FDA INSPECTION
The New Jersey site achieved a successful pre-approval inspection by the FDA.
-
PHARMTECH FEATURE
Video interview features Dean Bornilla discussing growth of Pace® Life Sciences
-
-
FILL-FINISH FEATURE
Contract Pharma features Frank Tagliaferri amongst other industry leaders in Fill-Finish Roundtable
-
EXPANSION ANNOUNCEMENT
New Hampshire and Minnesota labs announce expanding operations for biopharma services
-
LABORATORY ACQUISITION
Pace® Life Sciences acquires Research Triangle Park, NC lab from Catalent.
-
BIOPHARM FEATURE
BioPharm International features Frank Tagliaferri discussing drug delivery
-
-
-
-
NEWS
Pace® Life Sciences Announces Successful Pre-Approval Inspection from US FDA in Lebanon, NJ
-
NEWS
Future role of Pace® Life Sciences in supporting biopharmaceutical development and manufacturing coast-to-coast – Dean Bornilla, Vice President.
-
NEWS
Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability
-
NEWS
Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences
-
NEWS
Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025
-
NEWS
Pace® Life Sciences Expands Capacity and Capability with Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park
-
NEWS
Exploring Innovative Means for Biologics Delivery - Dr. Frank Tagliaferri, Pace® Life Sciences
-
NEWS
Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN
-
-
-
-
RESOURCE LIBRARY
Regulatory Affairs Resource Library
Bring your molecule to market with insights to advance your program along the relevant regulatory affairs pathway. -
Explore our range of services
Wherever you are in your drug development journey, we can help.
THE RIGHT PARTNER FOR YOUR PROJECT
We have a nationwide network of state-of-the-art facilities, each with long-established histories of successful product development and commercialization and excellent audit outcomes from regulatory agency and client reviews.
FDA
REGISTERED
DEA
DEA Schedules I – V
GMP
COMPLIANT
ISO
17025 ACCREDITED
OUR PROMISE TO YOU
We honor our commitments so you can honor yours™. Our investment in state-of-the-art facilities and highly trained experts emphasizes our commitment to delivering positive customer experiences across all phases of pharmaceutical and biopharmaceutical development.
- RELIABLE DELIVERY
- COLLABORATIVE RELATIONSHIPS
- EXCEPTIONAL SERVICE
IT ALL STARTED IN 2006
Since 2006, Pace® Life Sciences has continued to prioritize strategic investments and domestic acquisitions to meet the changing needs of our customers. As the market changes, we are committed to making sure we are positioned as the best U.S. owned and operated end-to-end solution for your program.

Conferences

INTERPHEX 2025
The leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference.
April 1-3, 2025 | Javits Center, NYC
feature webinar

Overview of FDA’s Expedited Programs for Serious Condition
Recognize the importance of expedited review programs, such as FTD, BTD, and RMAT Designation, and their impact on reducing drug development time.
Now available on demand